Start here if you're new
what it is
Kulicke & Soffa makes machines and services that help chipmakers assemble and test semiconductors.
how it gets paid
Last year Kulicke & Soffa made $654M in revenue. Ball Bonding was the main engine at $0.29B, or 45% of sales.
why growth slowed
Revenue fell 7.4% last year. The $200M revenue print matters because it rose 20% vs. prior year while EPS still fell 79%.
what just happened
Kulicke & Soffa posted $200M in revenue, but EPS and margins still look like a recovery, not a victory lap.
At a glance
B balance sheet — gets the job done, barely
30/100 earnings predictability — expect surprises
311.7x trailing p/e — you're paying up for this one
1.4% dividend yield — cash in your pocket every quarter
16.5% return on capital — nothing to write home about
xvary composite: 52/100 — below average
What they do
Kulicke & Soffa makes machines and services that help chipmakers assemble and test semiconductors.
Ball Bonding brought in 45% of FY2025 revenue. That is the cash engine. R&D → research spending → so what: it ate 23% of FY25 sales, and 90% of revenue came from outside the U.S., so your customer base is global and your spending stays heavy.
How they make money
$654M
annual revenue · their business grew -7.4% last year
Ball Bonding
$0.29B
Aftermarket Products & Services
$0.16B
Wedge Bonding
$0.11B
Advanced Solutions
$0.07B
All Other
$0.02B
The products that matter
semiconductor assembly equipment
Assembly Equipment & Services
$654M revenue · 100% of sales
it's the entire business. if orders recover, almost everything improves at once. if customers pause spending, there is nowhere else to hide.
100% of revenue
Key numbers
311.7x
trailing p/e
You are paying 311.7 times last year’s earnings for a cyclical chip-tool maker. That is a rebound story with a very expensive wrapper.
$654M
annual revenue
This is the size of the business. You are looking at a $654M company with a roughly $3B market cap.
$75
18-mo target
That is about 15% above the current $65.45 price. The market is already paying for some recovery.
1.4%
dividend yield
You get paid 1.4% while waiting. That is not much cushion for a stock this loud.
Financial health
B
strength
- balance sheet grade B — adequate — nothing special
- risk rank 3 — safer than 50% of stocks
- price stability 30 / 100
- net profit margin 17.0% — keeps 17 cents of every dollar in revenue
- return on equity 16% — $0.16 profit for every $1 investors have put in
B — functional but not a standout on the balance sheet.
Total return vs. market
You invested $10,000 in KLIC 3 years ago → it's now worth $13,230.
The index would have given you $14,540.
source: institutional data · total return
What just happened
beat estimates
Kulicke & Soffa posted $200M in revenue, but EPS and margins still look like a recovery, not a victory lap.
Latest quarter revenue was $200M, up 20% vs. prior year. EPS was $0.32, while gross margin held at 49.6%.
$200M
revenue
$0.32
eps
49.6%
gross margin
the number that mattered
The $200M revenue print matters because it rose 20% vs. prior year while EPS still fell 79%, so the recovery is uneven.
-
kulicke & soffa’s fiscal 2026 first-quarter results signaled a decisive recovery in the semiconductor equipment cycle. (year began october 6th.) the company reported net revenue of $199.6 million, a 20% vs. prior year increase that comfortably cleared consensus expectations.
-
adjusted earnings reached $0.44 per share, crushing our forecast by 47% while expanding 19% from the same prior-year period.
-
this performance was driven by a 27% sequential jump in general semiconductor revenue and healthy capacity expansion in the memory market, where utilization rates for ball bonding exceeded 85%.
-
operational momentum is currently focused on the high-growth ai and advanced packaging sectors.in early 2026, management confirmed the first shipment of its high-bandwidth memory (hbm) system to a major customer, marking a critical entry into the ai accelerator supply chain. k&s is also seeing significant traction with its fluxless thermocompression bonding (tcb) solutions, which are emerging as a preferred alternative for next-generation hbm needs.
-
k&s expects an accelerated growth trajectory throughout fiscal 2026.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the risk here is not abstract. KLIC has one operating segment, just finished a $654M revenue year, and still needs the recent rebound data to spread beyond one quarter.
med
cycle reversal
revenue fell 7.4% last year to $654M. if the recovery stalls after one better quarter, the $900M fiscal 2026 expectation starts looking too generous very quickly.
because Assembly Equipment & Services is 100% of revenue, a slowdown hits the whole company at once.
med
advanced packaging staying small
the first high-bandwidth memory shipment is a good sign. it is still one shipment. the market will want follow-through before it treats this as a real growth lane.
if that traction stays thin, you are left underwriting a cyclical assembly-tool business at roughly 25.7x forward earnings.
med
earnings whiplash
quarterly EPS swung from $0.37 to -$0.52 to $0.07 to $0.28. the 30/100 predictability score is saying the same thing with less drama.
when profits bounce around this much, the stock can stop trusting forward estimates long before management does.
The key insight: there is no second engine here. If semiconductor assembly demand and newer packaging wins do not keep improving, the rebound thesis loses its only support beam.
source: institutional data · regulatory filings · risk analysis
Pay attention to
key metric
revenue vs. the $900M target
the street expects fiscal 2026 revenue to reach $900M from $654M. that's the cleanest scorecard for whether this rebound is real or just one good quarter.
trend
advanced packaging traction
watch for follow-on high-bandwidth memory shipments and more commentary around fluxless thermocompression bonding. one shipment is a headline. repeat orders are a business.
earnings
quarterly EPS consistency
after a four-quarter run of $0.37, -$0.52, $0.07, and $0.28, you want to see fewer surprises and more evidence that margins are stabilizing.
risk
institutional flow
institutions were net sellers for two straight quarters. if that flips while orders improve, the market is starting to believe the recovery story with real money.
Analyst rankings
short-term outlook
average
momentum score 3. in human-speak, analysts think the setup is ordinary right now, not a clear short-term breakout.
risk profile
average
stability score 3 means the balance sheet risk sits near the middle of the pack, even if the stock itself still swings around.
chart momentum
average
technical score 3 says the chart is behaving normally. no strong momentum push, but no obvious technical collapse either.
earnings predictability
30 / 100
low predictability means estimates can move fast. that fits a company whose quarterly EPS just swung from negative to positive within a few quarters.
source: institutional data
Institutional activity
institutions have been net selling for 2 consecutive quarters — 105 buyers vs. 113 sellers in 4q2025. total institutional holdings: 45.4M shares. net selling for 2 quarters.
source: institutional data
Price targets
3-5 year target range
$45
$104
$65
current price
$75
target midpoint · +15% from current · 3-5yr high: $130 (+100% · 20% ann'l return)
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive